Dr. Jean-Mathieu Beauregard, MD,MSc,FRCPC
Claim this profileStudies Neuroendocrine Tumors
Studies Neuroendocrine Carcinoma
1 reported clinical trial
1 drug studied
More about Jean-Mathieu Beauregard, MD,MSc,FRCPC
Clinical Trial Related8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jean-Mathieu Beauregard, MD,MSc,FRCPC has experience with
- 177Lu-Octreotate
Breakdown of trials Jean-Mathieu Beauregard, MD,MSc,FRCPC has run
Neuroendocrine Tumors
Neuroendocrine Carcinoma
Carcinoid Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jean-Mathieu Beauregard, MD,MSc,FRCPC specialize in?
Jean-Mathieu Beauregard, MD,MSc,FRCPC focuses on Neuroendocrine Tumors and Neuroendocrine Carcinoma. In particular, much of their work with Neuroendocrine Tumors has involved treating patients, or patients who are undergoing treatment.
Is Jean-Mathieu Beauregard, MD,MSc,FRCPC currently recruiting for clinical trials?
No, Jean-Mathieu Beauregard, MD,MSc,FRCPC is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jean-Mathieu Beauregard, MD,MSc,FRCPC has studied deeply?
Yes, Jean-Mathieu Beauregard, MD,MSc,FRCPC has studied treatments such as 177Lu-Octreotate.
What is the best way to schedule an appointment with Jean-Mathieu Beauregard, MD,MSc,FRCPC?
Apply for one of the trials that Jean-Mathieu Beauregard, MD,MSc,FRCPC is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.